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Research Article
The Impact of an Epilepsy Self-Management Program on Healthcare
Utilization and Related Costs
—Emily Dwyer (Editor: Rosie Donegan, Jennifer Lee)
A chronic medical condition such as epilepsy requires a lifetime of monitoring and management by a
medical team and the patient. The treatment is often multidisciplinary and can include medication,
surgery, education, and self-management. This last approach focuses on teaching patients to monitor
and respond to symptoms on their own while utilizing their healthcare team for guidance and support.
For ten weeks during the summer of 2015, I participated as an intern in evaluating the cost
effectiveness of Home Based Self-Management and Cognitive Training Changes Lives
(HOBSCOTCH), an epilepsy self-management program developed at the Dartmouth-Hitchcock
Epilepsy Center. The center is staffed by nurse practitioners, physicians, and nurses who specialize in
epilepsy treatment, and who also conduct research on epilepsy and its management. HOBSCOTCH is
an experimental program and is not offered as a part of general epilepsy care at this time.
My internship was part of the IDeA
Network for Biomedical Research
Excellence (INBRE) Summer
Undergraduate Research Fellowship
(SURF) in Nursing. This program
receives funding from the National
Institutes of Health with the aim of
increasing undergraduate research
opportunities in the state of New
Hampshire. As a junior nursing
major, I applied for this summer
program because research
opportunities in nursing are rare for
undergraduates. Often nursing is seen
as a purely clinical profession, when
in reality research is the backbone of
all clinical skills.

The author presented her research at the New Hampshire
IDeA Network of Biomedical Research Excellence annual
meeting at the Wentworth by the Sea Hotel in New Castle,
NH, August 2015 (Photo by Jon Gilbert Fox).

The HOBSCOTCH program ran from
January of 2013 to June of 2014, and
the effectiveness of the program was then evaluated. When I began my internship in June of 2015, the
research team wanted to assess the cost effectiveness of the program. I helped accomplish this by
focusing on how the program impacted participants’ utilization of the healthcare system.

What is Epilepsy?

Before my internship, I did not have an extensive knowledge of epilepsy or its management, but I
learned much more by shadowing my mentor in the epilepsy clinic and inpatient unit. Additionally, I
was able to observe a surgery on an epilepsy patient. These clinical experiences, in combination with
my own research on the subject, helped me to learn a lot about epilepsy and just how great of an
impact it can have on someone’s life.
More than four million adults in the United States have a diagnosis of epilepsy (4). This is a chronic
condition in which an individual experiences recurring seizures (10). Cerebral neurons that ordinarily
discharge electrical impulses to complete a specific task, fire suddenly and excessively (10). Epilepsy
can be either primary or secondary, and the resulting seizures from both are classified as generalized
or focal (partial). Primary epilepsy is idiopathic, meaning it has no known cause, although there may
be genetic components. Secondary epilepsy is the result of an underlying condition such as a brain
tumor. The resulting seizures present differently in each person and are dependent on the location and
type of seizure.
A generalized seizure rapidly engages neurons in both hemispheres and is the type of seizure that
most people have heard of. It involves the rhythmic contraction and relaxation of muscles, and the
individual often loses consciousness. A focal, or partial, seizure involves only one hemisphere of the
brain. The whole body is typically not involved, and there are a number of different presentations,
such as the twitching of one limb, behavioral changes, staring, or loss of muscle tone.
A number of treatment options exist for individuals with epilepsy, but these do not guarantee freedom
from all symptoms. Patients and providers struggle to maintain the balance between a safe, effective
medication dose and the numerous possible side effects. Examples of side effects are dizziness,
sedation, weight gain, and cognitive slowing, among many others. Surgery is another treatment
option if medication options are not successful. When an individual’s epilepsy stems from a singular,
well-defined area of the brain, this section may be removed to help control the individual’s epilepsy.
Depending on the location, there can be a number of physical and cognitive effects. Another option is
the surgical placement of a vagus nerve stimulator (VNS). Similar to a cardiac pacemaker, it is placed
in the chest and sends electrical impulses to the brain via the vagus nerve. Individuals can induce
additional electrical impulses during the onset of a seizure. These impulses help to reduce seizure
severity and frequency.
HOBSCOTCH and Memory Impairment

Many individuals with epilepsy report cognitive impairments, particularly regarding memory (5). As
a result, HOBSCOTCH was designed to specifically address memory impairment in those with
epilepsy. Multiple factors contribute to memory impairment, including both the seizures themselves
and the form of treatment. Regardless of cause, the treatment of cognitive changes due to epilepsy is
multidisciplinary and involves general medication management, behavior management, support, and
memory and cognitive training (7). HOBSCOTCH specifically aims to help patients by providing this
training and support.
The program structure includes an initial group visit; six individual, weekly telephone sessions; and a
final visit. Each of these takes place with a memory coach, a nurse practitioner or nurse who
specializes in epilepsy and has received training in problem solving therapy. In this therapy, the
coach teaches the patient how to assess external factors, such as the environment, and internal factors,

such as feelings, that contribute to memory impairment. The memory coach can then use different
strategies to help the patient work with these contributing factors (3).
During the initial group visit at the medical center, patients are educated on epilepsy and how it
affects cognitive function, with an emphasis on memory. The patients are then introduced to the
program, given a workbook and a day planner. In the planner, patients record seizure activity and
write down events they need to remember. Pages in the workbook are dedicated to each week of the
program. Here they record any memory problems they are experiencing and brainstorm ways to work
with them. Patients are prompted to evaluate the pros and cons of each potential solution and pick the
most appropriate one. They then put the chosen plan into action and evaluate it at the next weekly
telephone session. During these sessions the coach teaches them new strategies to work with memory
impairment and offers support. The program concludes with the final, in-person visit.
Between January 2013 and June 2014, a total of fifty-seven patients participated in the
HOBSCOTCH program. These patients all had subjective, or self-reported, memory complaints;
were between eighteen and sixty-five years of age; had an IQ above 70; no difficulty reading or
writing; reliable telephone access; and were on a stable medication regime (antiepileptics and
antidepressants) for at least one month. The fifty-seven patients were randomized into one of three
groups: those who participated in the program (the intervention group), the intervention plus
computerized cognitive training group, and the control group. Those in the computerized cognitive
training group participated in HOBSCOTCH and additionally used a Nintendo DS for cognitive
training. Those in the control group did not participate in HOBSCOTCH and received care as usual.
In the follow-up evaluative study in 2014, the primary outcome, or variable of interest, was quality of
life. The Quality of Life in Epilepsy (QOLIE-31) questionnaire was used to measure this variable.
One secondary outcome was objective memory, or memory that can be measured through cognitive
testing such as the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
Another secondary outcome was mood, measured by depression scores calculated from the Patient
Health Questionnaire (PHQ-9). All participants filled out these questionnaires at the beginning and
end of the program.
The study found that HOBSCOTCH was effective in improving objective memory, particularly with
regard to attention (3). This was demonstrated by a statistically significant increase in scores on the
RBANS for those in the two intervention groups as compared to those in the control group. While
there was an increase in quality of life for those in the intervention groups, it was not found to be
statistically significant. Depression scores, as measured by the Patient Health Questionnaire (PHQ-9),
did not change significantly for those in the intervention or control groups. No statistically significant
difference was observed between the two intervention groups.
Measuring Cost Effectiveness of HOBSCOTCH

My research over the summer of 2015 involved evaluating the results of the 2013-2014
HOBSCOTCH program in terms of its cost effectiveness. Karen Secore, APRN, was one of the
clinicians researching HOBSCOTCH and became my mentor. Given the short, ten-week timeline and
our resources, Karen and I chose to evaluate cost effectiveness by measuring healthcare utilization
before and after HOBSCOTCH was implemented. Our goal was to determine if a self-management
program like HOBSCOTCH could be effective in decreasing healthcare costs in addition to helping
patients meet specific health goals.

Healthcare utilization data provides information on how often and which healthcare services patients
utilize. I conducted a literature review on how healthcare utilization data has been used to measure
cost effectiveness. The simplest method is to compare the number of encounters with the healthcare
system the patient has before and after an intervention (1). This data can be further related to actual
healthcare costs (6, 10, 11), and it can be combined with secondary measures, such as quality of life
data, to further examine the effectiveness as well as cost of an intervention (12). I found that studies
similar to ours had been usually conducted in the primary care setting (2). Some studies have
additionally focused on patients with a higher than average number of encounters (8). This review
validated the process we had chosen to use.
I analyzed the medical records of the fifty-seven participants to determine healthcare utilization six
months before and six months after
participating in the program by counting
the number of encounters during those
periods. These encounters included
outpatient visits, telephone calls,
emergency department visits, admissions,
surgeries, and diagnostic tests. Outpatient
visits and phone calls were divided into
those specific to the neurology
department and those with other
departments to determine if the program
affected neurology encounters more than
others.
Fig. 1: Comparing total encounters and neurology encounters
for the high frequency group before and after HOBSCOTCH.
For this study both intervention groups
Total Encounters: p=0.001* Neurology Encounters: p=0.886.
were combined as there was no
*Statistical Significance, p<0.05
significant difference in outcomes for
these groups. In addition, eighteen
patients who had five or more encounters
in the six months prior to the program
were categorized as high frequency
patients. We wanted to look at this group
separately to determine if HOBSCOTCH
was more effective for these individuals
than for others.
I analyzed the data using SPSS statistics
software version twenty-one. When
looking at the combined intervention
group, I found a decrease post-program in
Fig. 2: Comparing total encounters and neurology encounters
both total and neurology encounters, but
before and after the HOBSCOTCH program. Total
the decrease was not statistically
significant (p>0.05). However, there was Encounters: p=0.246 Neurology Encounters: p=0.548
a statistically significant decrease in the
total number of encounters for those in the high frequency group (p = 0.001). (See Figures 1 and 2)
I then took the depression and quality of life data from the first study and compared it to the data on
neurology encounters. Before the program, high depression scores (meaning a deeper depression)

were associated with a high number of neurology encounters. Low quality of life scores were also
associated with a high number of encounters. This means that patients with depression and/or a
decreased quality of life had more neurology encounters.
After the patients completed HOBSCOTCH, high depression scores and low quality of life scores
were not always associated with a high number of neurology encounters. In the control group high
depression scores continued to be associated with a high number of neurology encounters although
low quality of life scores were not.
What can this Mean?

This study found that HOBSCOTCH lowers the number of healthcare encounters in those who utilize
the healthcare system more than others, that is, the high frequency group. While these are positive
results, they also highlight a bigger picture. The program aims to help patients manage a particular
healthcare problem: memory impairment related to epilepsy. Improving a patient’s memory improves
his/her quality of life and can also help decrease healthcare encounters. For example, memory
impairment can contribute to not consistently taking medications. This can lead to an increased
occurrence of seizures and poor control of other health conditions, which in turn lead to more
healthcare encounters. After participating in HOBSCOTCH, the total number of encounters
decreased in patients in the high frequency group. It is hypothesized that this decrease is the result of
improved memory.
As a part of the program, patients learn to recognize and manage memory impairment, which
contributes to a decrease in the number of total healthcare encounters. This decrease results in a
lowering of healthcare costs to both the patient and the healthcare system.
The effect HOBSCOTCH has on healthcare utilization can also be seen in its effect on the association
between depression, quality of life, and the number of neurology encounters. After participating in
the program, low quality of life and/or high depression scores did not always result in a high number
of neurology encounters. This suggests that the program empowers patients by giving them the tools
to self-manage and cope with the cognitive changes associated with epilepsy.
The small sample size is a limitation of this study. Fifty-seven and eighteen patients are relatively
small sample sizes. A larger sample size would be needed to further generalize results. In addition,
the increased number of encounters experienced by those in the high frequency group and the
subsequent decrease could be random.
Overall, these results make the case that self-management programs, both in epilepsy and in other
chronic health conditions, can have a multitude of effects. This is particularly true for patients who
utilize the healthcare system more than others. Rather than continuing to treat a problem solely with
medication, providers can offer education and support, which can empower patients to better manage
their conditions and decrease their number of healthcare encounters.
Conducting this research helped me to grow as a nurse. It opened my eyes to the role nurses play in
research, and to the extensive amount of work conducted behind the scenes of research studies. As I
move forward in my nursing career, I plan to attend graduate school, which will involve conducting
research. Before completing this internship, my skill set was primarily clinical. At this point, I know
that my knowledge can be applied in a research setting, and that conducting research is very
rewarding. I have gained a new sense of confidence in myself and an appreciation for research in

nursing. In addition, I learned about what it takes to conduct research, and how you can learn a lot
from negative results.

There are many people whom I would like to thank for making this research experience possible.
First, the INBRE ISURF program gave me the opportunity to conduct research as an undergraduate
nursing student. Staff from both Dartmouth College and Dartmouth-Hitchcock Medical Center
worked together to make this program possible. Second, I would like to thank Karen Secore, Dr.
Barbara Jobst, and the rest of the HOBSCOTCH team for allowing me to spend the summer with
them. It was an honor to work with them on a program that they created for their patients. Finally, I
would like to thank Dr. Susan Fetzer for bringing this opportunity to my attention, and helping me
use the research as a part of my honors thesis. It has been an invaluable experience.
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